The effect of dopamine replacement therapy on haptic sensitivity in Parkinson's disease.

Journal of Neurology
Kuan-Yi LiJürgen Konczak

Abstract

Increasing evidence indicates that processing of proprioceptive information is altered in Parkinson's disease (PD), leading to reduced kinaesthetic and haptic sensitivity. However, there is inconclusive evidence whether dopamine replacement therapy (DRT) ameliorates or worsens kinaesthetic and haptic function in PD. For assessing perceptual function, we employed a task that did not require active motion or stressed working memory function, which may become impaired in PD. A group of mild to moderate stage PD patients (n = 9) and a group of age-matched healthy controls participated in this study. Without vision, a subject's hand was moved by a robotic manipulandum along the contours of a small "virtual box" (5 × 15 cm). At the end of each trial, they indicated whether the contour was "curved" or "straight". PD patients were tested ON and OFF antiparkinsonian medication. Psychophysical detection thresholds were determined (curvature at which subjects correctly perceived a curved contour at the 75% level). Compared to the control group, thresholds were elevated by 55% in the PD patient group. During the ON medication state, the mean detection threshold of the patient group was reduced by 15% (ON: 4.71 m(-1); OFF: 5.42 m(-1)). Incr...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Apr 1, 1987·Brain : a Journal of Neurology·R BeneckeC D Marsden
Feb 1, 1985·Journal of Neurophysiology·M R DeLongA P Georgopoulos
Jan 1, 1984·Experimental Brain Research·M D Crutcher, M R DeLong
Jul 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·T KlockgetherJ Dichgans
Jan 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·L T Robertson, J P Hammerstad
Jan 1, 1997·Perception & Psychophysics·K Sathian, A Zangaladze
Apr 1, 1997·Archives of Neurology·E E JobstM J Aminoff
Aug 28, 2001·Brain : a Journal of Neurology·M C Rodriguez-OrozJ A Obeso
Oct 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·P O'SuilleabhainR B Dewey
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Giovanni Abbruzzese, Alfredo Berardelli
Jun 25, 2003·Brain : a Journal of Neurology·Matthias MaschkeJürgen Konczak
Mar 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·M MaschkeJ Konczak
Feb 17, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Norman PutzkiMatthias Maschke
Apr 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Matthias MaschkeJürgen Konczak
Aug 26, 2006·The European Journal of Neuroscience·Attila NagyGyörgy Benedek
Oct 10, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Benjamin G ClissoldPeter A Kempster
Apr 11, 2007·Journal of Neurology·Jürgen KonczakMatthias Maschke
Mar 18, 2008·Journal of Neurology·Birgit HertingThomas Hummel
Jul 10, 2008·PloS One·Jürgen KonczakHoward Poizner
Jul 14, 2009·Journal of Motor Behavior·Jürgen KonczakMatthias Maschke

❮ Previous
Next ❯

Citations

Mar 25, 2011·Psychopharmacology·Matthew A AlbrechtFlavie Waters
Nov 13, 2013·Nature Reviews. Neurology·Antonella ConteAlfredo Berardelli
Nov 22, 2012·Brain : a Journal of Neurology·Jürgen KonczakGiulio Sandini
Dec 3, 2014·Physiology & Behavior·Richard L DotyFidias E Leon-Sarmiento
Dec 17, 2014·Frontiers in Human Neuroscience·Giovanni AbbruzzeseElisa Pelosin
Nov 19, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Joshua E AmanJürgen Konczak
Mar 5, 2019·Journal of Parkinson's Disease·Odette FründtKatharina Schmidt
Apr 25, 2014·Journal of Neurophysiology·Joseph SniderHoward Poizner
Jul 7, 2015·European Journal of Pain : EJP·R G CuryD Ciampi de Andrade
Aug 7, 2018·Frontiers in Neurology·Laura AvanzinoAntonella Conte
Jan 9, 2019·Frontiers in Neurology·Naveen ElangovanJürgen Konczak
Mar 11, 2021·Experimental Brain Research·Erin K CressmanDenise Y P Henriques

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.